There’s a new coronavirus vaccine that has the science community feeling hopeful. Johnson & Johnson released Phase 3 trial data on Friday (January 29), showing that their vaccine – a single shot – is 66% effective at preventing symptomatic disease and 85% effective against severe illness, ABC reports.
A team of scientists at the company were “elated” by the results. “We’re a single shot…and now we’ve produced data that say that our vaccine is highly effective, 85% effective against severe COVID, 100% effective against hospitalization or death,” Dr. Mathai Mammen, M.D., Ph.D.
and the global head of Janssen Research & Development said. “We’ve had the objective of producing a vaccine for the world, that is easily used, is easily distributed
Read more on justjared.com